Introduction

This comprehensive volume explores the transformative yet complex role of nanotechnology in reproductive health, balancing its revolutionary diagnostic and therapeutic potential with emerging toxicological and ethical challenges.

The book systematically details how nanomaterials are reshaping Assisted Reproductive Technologies (ART), targeted drug delivery, and next-generation contraception. It also presents a critical evaluation of the adverse impacts of environmental and engineered nanoparticles on male and female reproductive systems, detailing their disruption of neuroendocrine axes, gamete interactions, and placental barriers. Furthermore, the text bridges the gap between bench and bedside by examining the clinical translation of nano-therapeutics for reproductive cancers, alongside rigorous discussions on global ethical, regulatory and socio-economic frameworks required for safe implementation.

Key Features

• - Covers several aspects of nanotechnology applications for Assisted Reproductive Technologies and reproductive health.
• - Integrates cutting-edge multi-omics research, transgenerational toxicity data and predictive modeling.
• - Practical Insights: Provides a balanced "safe-by-design" perspective with actionable insights for International regulatory harmonization.
• - Offers a dual focus on both clinical therapeutic opportunities and environmental hazard mitigation.

Target Readership :

Primary: Reproductive biologists, nanotoxicologists, endocrinologists, and bioethicists.

Secondary: Pharmacologists, regulatory policymakers, environmental health scientists, and graduate students in biomedical and nanoscience.